Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. - Wikidata - wikimedia - TriplyDB

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

http://www.wikidata.org/entity/Q34129787

about

Hysterectomy versus hysterectomy plus oophorectomy for premenopausal women Structural determinants of the BRCA1 : estrogen receptor interaction Family information service participation increases the rates of mutation testing among members of families with BRCA1/2 mutations Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers BRCA mutations and childhood cancer 25th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 10-14 December 2002 Update on preclinical and translational research The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer.Oestrogen exposure and breast cancer risk Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer.Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation.Ovarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease Prevention Ovarian Cancer: The Fallopian Tube as the Site of Origin and Opportunities for Prevention The Consequences of a BRCA Mutation in Women BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact?BRCA1, a 'complex' protein involved in the maintenance of genomic stability Plant sterols as anticancer nutrients: evidence for their role in breast cancer Cancer biomarkers Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers The oviduct and ovarian cancer: causality, clinical implications, and "targeted prevention"Feasibility evaluation of an online tool to guide decisions for BRCA1/2 mutation carriers.Characterization of BRCA1 and BRCA2 mutations in a large United States sample Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers Pre-counseling education for low literacy women at risk of Hereditary Breast and Ovarian Cancer (HBOC): patient experiences using the Cancer Risk Education Intervention Tool (CREdIT).Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.An overview of optical coherence tomography for ovarian tissue imaging and characterization.Correlating optical coherence elastography based strain measurements with collagen content of the human ovarian tissue.Advances in tumor screening, imaging, and avatar technologies for high-grade serous ovarian cancer.A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study.Potential role of coregistered photoacoustic and ultrasound imaging in ovarian cancer detection and characterization.The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer--a population-based data linkage study.Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma: 10-year follow up data.Progress and challenges in screening for early detection of ovarian cancer.Do breast cancer survivors benefit from prophylactic removal of uterus and ovaries? A population-based data linkage replication study.Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: an initial evaluation from a screening trial including magnetic resonance imaging and ductal lavage.Influence of the MDM2 single nucleotide polymorphism SNP309 on tumour development in BRCA1 mutation carriers.Incorporating medical interventions into carrier probability estimation for genetic counseling.BRCA1 interaction with human papillomavirus oncoproteins.Coordinated prophylactic surgical management for women with hereditary breast-ovarian cancer syndrome.Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family.

P2860

Q24194792-A4B4B0B7-704B-4FAB-A4DD-B90D820CBF3B Q24292926-D342550F-42CB-4884-B401-04039C5078AD Q24655010-383D3F96-C87F-437D-980F-B547C0C16DE7 Q24655824-6BDF3A79-3DAC-4599-805F-F475F2E4D224 Q24655952-4B7F93E9-6DDC-4C4B-99D8-5CD2F495A091 Q24795635-56E4A719-7C9C-45E5-903B-165364929030 Q24796156-51312927-A76F-4E37-9E16-15EECF50CE1F Q24803498-F4DBAF66-2D11-43FD-9779-D9C4C5FC76C2 Q25257326-6F197969-D4D8-46C6-8E00-3C918DE1F6EF Q25257803-91C28115-17A3-47ED-A9EC-62A32F2065C0 Q26744525-107DEF69-A98F-4961-BC77-59AA4B970306 Q26747279-EF5F86E6-BEA1-4D16-980D-23BFC57BA525 Q26777891-31DC12CE-CD54-4737-965B-77B8F4220955 Q26822737-A63EC0A6-A772-4F95-A1DF-5B9486A8E2C4 Q26853262-2FDDF21A-54ED-47C3-9217-AD3195A8BD13 Q26861053-6734BFA8-189D-4FA2-BAC9-87820E3E3B59 Q26864429-4395D57A-F60B-4299-B6F0-8123CDC0CC41 Q27003935-0606D0E2-25DD-494E-B0D3-404693C91697 Q27025315-579CA03C-345E-4BC1-8AF0-59B544F989E1 Q27316521-95B7A1E7-362A-4275-B3CA-132FDB213C39 Q28383993-F65BF0FB-E692-41FA-8577-AE011D41D936 Q28386156-88A78F8D-1FE9-4BB9-92EB-514E32F4762F Q30227158-28286DD8-848A-4F8F-9B74-14F973CE7B3A Q30370475-13A64B05-0703-4A71-B4D0-B4A1CB2297C5 Q30395093-54E094F7-81FC-41FA-A7FD-4B1A484FA89C Q30400512-D43D295F-27F3-4DC5-ACE3-5B1BAF75AA26 Q30423597-BC3F29C0-EDD6-44DE-B1AA-D295736EA330 Q30431721-EE374858-D580-4C57-832F-782C4C1ADA8A Q30433319-A1EF2269-7503-4B9B-A779-CD01A52A30DA Q30477398-0FD6BCDB-EEED-461A-96C7-1EBDD007A1EB Q30677729-EB76C58B-BD53-4BE7-ACB6-C49476484F30 Q30764147-F65538D8-AF7D-4217-8235-CCA87E731838 Q31041170-E738BA3F-6064-478A-AEE8-2BE85396F5FE Q31102791-DCCC40B4-19E2-4409-9378-09DB2B0081BB Q33221678-88B19114-D423-4B81-8F73-26B24DD54B66 Q33237559-B6BEF87F-1BD7-4602-ADF9-D5439322A627 Q33279688-38145D97-22B1-4B23-8C98-F0EB9B6232AE Q33292263-55C6E6EC-9CFE-47CA-8969-FD355628A120 Q33328135-363EFE5E-E5BD-4166-8FED-4DF5E99FD23A Q33338978-5ED96043-2BF0-4043-95BF-11E2E38B15D6

P2860

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

http://www.wikidata.org/entity/Q34129787

description

2002 nî lūn-bûn

@nan

2002 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

@ast

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

@en

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

@nl

type

label

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

@ast

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

@en

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

@nl

prefLabel

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

@ast

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

@en

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

@nl

P1433

Q34129787-52A2FA81-E877-4754-ABA2-9B0DBADFB4AA

P1476

Q34129787-90553946-04C3-4F84-8359-19C0FC1A8CDF

P2093

Q34129787-027BF160-5188-4577-83D0-C064E1C16430

Q34129787-5CB370BE-B72C-45C4-A557-DE7127CA6115

Q34129787-62BFD079-0E2F-47A2-9174-72A1EFB0E9F6

Q34129787-7965C1C2-8B35-41DA-985B-97FEB47F7702

Q34129787-BA917101-FDAC-4FB1-8CA2-35CD443B3D76

Q34129787-D1D8C413-1315-4763-8496-3EA8A28D1877

Q34129787-DE7F382F-66E8-41B4-820D-15DF778C048C

Q34129787-E30E5E3E-7BA8-439F-9B84-A21913DFF639

P304

Q34129787-E33D7056-A5DB-4EB5-996F-17CFD866772F

P31

Q34129787-29C1A546-47DC-4039-AFCD-D52AF9C2D7F1

P356

Q34129787-9F73E955-18F5-4BF6-9800-5DCA25CEFC1B

P407

Q34129787-59D10B7E-77F1-4EFB-A5A6-939D0B85F0B1

P433

Q34129787-9BCA465F-C739-44F3-A328-177E2EEE16AE

P478

Q34129787-0443B68D-3944-4978-8B91-0108A5757310

P50

Q34129787-17EA687E-8CC4-4239-82BB-BC017B18083A

Q34129787-2213432B-DD4B-4012-B02C-B567524CDFA4

Q34129787-2EC4BB35-F4B5-4BC7-BB28-7B97B6001C6E

Q34129787-5C0774EC-6513-4DD8-9B70-C5F98F0B42B5

Q34129787-FA9B1F0E-E097-4F8C-B681-15F952690005

P577

Q34129787-49D17019-053F-4CF2-8C55-A5CCE5E3523A

P698

Q34129787-04A13791-4CC7-4C43-B01C-5BF77E3B2AA7

P356

P1433

The New England Journal of Medicine

P1476

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

@en

P2093

Barbara L Weber

http://www.w3.org/2001/XMLSchema#string

Ellen Matloff

http://www.w3.org/2001/XMLSchema#string

Henry T Lynch

http://www.w3.org/2001/XMLSchema#string

Judy E Garber

http://www.w3.org/2001/XMLSchema#string

Laura Van't Veer

http://www.w3.org/2001/XMLSchema#string

Mary B Daly

http://www.w3.org/2001/XMLSchema#string

Prevention and Observation of Surgical End Points Study Group

http://www.w3.org/2001/XMLSchema#string

Timothy R Rebbeck

http://www.w3.org/2001/XMLSchema#string

P304

1616-1622

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA012158

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

346

http://www.w3.org/2001/XMLSchema#string

P50

Steven A. Narod

Susan L Neuhausen

Olufunmilayo Olopade

Claudine Isaacs

P577

2002-05-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12023993

http://www.w3.org/2001/XMLSchema#string